Try our Advanced Search for more refined results
Health
-
March 06, 2026
Pa. High Court Snapshot: AG Powers, Gun Parts, CEO Bonus
The Pennsylvania Supreme Court this month will revisit a ruling on the state attorney general's power over civil suits brought by county-level district attorneys in a case stemming from the Philadelphia and Pittsburgh district attorneys' objections to a $26 billion opioid settlement.
-
March 06, 2026
Baker McKenzie Guides Servier On $2.5B Oncology Deal
French pharmaceutical group Servier said Friday that it has agreed to acquire Day One for about $2.5 billion in cash, with legal guidance from Baker McKenzie.
-
March 06, 2026
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen British American Tobacco sued by more than 100 investors, the government bring a claim against a COVID-19 supplier of personal protective equipment, Annington Funding sue its new corporate trustees on the Financial List, and Piers Morgan hit with a defamation claim from a pro-Israel barrister he interviewed on his YouTube channel.
-
March 06, 2026
Nurses' Holiday Pay Suit Against Health System Trimmed
A Colorado healthcare company will not face nurses' claims under state minimum-wage law alleging it miscalculated overtime wages, as a federal judge adopted a report concluding the statute does not cover "'pure overtime'" disputes when employees were paid at least the required minimum, court records show.
-
March 06, 2026
Cleary, Davis Polk Lead Diabetes Biz MiniMed's $560M IPO
Medtronic's diabetes-focused spin-off MiniMed Group began trading publicly Friday after pricing a $560 million initial public offering, well below the expected target of $742 million.
-
March 05, 2026
Telehealth Co. Swaps In Gordon Rees In Novo's GLP-1 Fight
A telehealth platform facing allegations from Novo Nordisk that it falsely advertised Ozempic alternatives has picked new counsel in the dispute, withdrawing attorneys from Foley & Lardner LLP and Miller Nash LLP and substituting in two lawyers from Gordon Rees Scully Mansukhani LLP.
-
March 05, 2026
A Look At Four States' Tort Reform Legislation Fights
There are currently four states debating whether to install business-friendly tort reform legislation or medical malpractice guardrails. The issues include a potentially brutal showdown in California over auto collision litigation and efforts in Florida to expand wrongful death liability for healthcare providers.
-
March 05, 2026
Ind. Justices Reverse Providers' Loss In COVID Immunity Row
Indiana's highest court ruled that over 80 healthcare providers are immune from a medical malpractice suit by the estate of a man who died after developing a bedsore while he was hospitalized for COVID-19, vacating a decision by a lower court of appeals.
-
March 05, 2026
9th Circ. Denies Bail Pending Nurse Wage-Fixing Appeal
A Ninth Circuit panel summarily refused to allow a Las Vegas home nursing executive to avoid prison while appealing the U.S. Department of Justice's first-ever criminal wage-fixing conviction.
-
March 05, 2026
Progenity Investors' $1M Billing Fraud Suit Deal Gets Final OK
Genetic test distributor Progenity Inc., now known as Biora Therapeutics Inc., has received final approval of a $1 million settlement with investors, resolving claims that it made misleading statements ahead of its June 2020 initial public offering about its practice of overbilling the government.
-
March 05, 2026
9th Circ. Judge 'Frustrated' At DOJ Position On Anti-Trans EOs
A Ninth Circuit judge said Thursday he's "very frustrated" with the Trump administration's argument that a district court judge acted prematurely by partly blocking executive orders to end funding for gender-affirming care, saying it's "pretty clear" the government was poised to do exactly that.
-
March 05, 2026
GAO Denies Protest Of $325M CDC Contract
The U.S. Government Accountability Office denied a protest over the awarding of a $325 million Centers for Disease Control and Prevention contract, finding the agency's extra round of discussions with the winning bidder did not result in an unequal process.
-
March 05, 2026
ApolloMD Reaches $4M Deal To End Data Breach Claims
Medical staffing company ApolloMD has reached a $4 million-plus settlement to end a lawsuit alleging the company's cybersecurity protocols led to the release of 662,000 people's personal information during a data breach last year.
-
March 05, 2026
Ex-Conn. Hospital Worker Drops Suit Over Post-Assault Firing
A former hospital maintenance worker injured in a workplace attack has ended his federal lawsuit against Stamford Health Inc. after the parties told a Connecticut federal judge they had reached an "agreement in principle" that needed approval from the state Workers' Compensation Commission.
-
March 05, 2026
Minn. Man Gets 5 Years For Jury Rigging In Fraud Case
A Minneapolis man has been sentenced to almost five years in prison for his role in a scheme to bribe a juror during the trial of Minnesota nonprofit Feeding Our Future, which was accused of stealing $250 million in COVID-19 relief funds earmarked to provide lunches to schoolchildren.
-
March 05, 2026
5th Circ. Upholds $919K Fee Award In Overtime Suit
The Fifth Circuit upheld an award of $919,000 in attorney fees to hospital employees who won an overtime pay dispute with Texas health providers, ruling Thursday that the lower court reasonably reduced a request for more than $3 million in fees.
-
March 05, 2026
Polsinelli Brings On McDermott Healthcare M&A Pro In Florida
Polsinelli PC has brought on a McDermott Will & Schulte partner in its Fort Lauderdale, Florida, office, strengthening its healthcare mergers and acquisitions practice.
-
March 05, 2026
Senior Living, Nursing Platform Sage Raises $65M In Series C
Senior living and skilled nursing platform company Sage said it has raised $65 million in a Series C equity round to help roll out new artificial intelligence-based resident safety tools, among other improvements.
-
March 05, 2026
BCBS Can't Nix NC Plan Member From Cancer Treatment Row
A North Carolina federal judge ruled a Blue Cross Blue Shield unit must face proposed class action claims over its administration of a state employee health plan from a participant alleging it arbitrarily characterized a proton beam cancer radiation treatment as experimental to deny coverage.
-
March 05, 2026
Doctor Can't Fight Records Order Tied To WWE Accuser's Suit
Connecticut's intermediate-level appeals court has turned away a celebrity doctor's challenge to an order that he and his Greenwich practice hand over payment records to a former patient who is suing World Wrestling Entertainment and co-founder Vince McMahon for alleged sex trafficking and abuse.
-
March 05, 2026
ERISA Recap: 6 Developments To Remember From Feb.
The Second Circuit refused to boot a former Luxottica worker's proposed class claims into solo arbitration, a Texas federal judge declined to snuff out a tobacco fee suit against 7-Eleven and a healthcare company inked a $43 million deal to wrap a case over how it handled 401(k) plan forfeitures. Here's a look back at six noteworthy moves in Employee Retirement Income Security Act cases from last month.
-
March 05, 2026
Fla. Lab Pays $980K To Settle Kickback Allegations
A laboratory in Florida agreed to pay $980,000 to resolve allegations that it provided kickbacks to marketers for referring Medicare beneficiaries to use its services, according to a Thursday statement from the U.S. Department of Justice.
-
March 05, 2026
Insurer Seeks Win In $6.3M Coverage Row With Pot Tester
James River Insurance Co. is asking a Mississippi federal court to grant it a win in its suit to deny coverage of a $6.3 million default judgment against a cannabis testing company, saying the company breached its policy by not cooperating with the insurer.
-
March 04, 2026
Wheeling & Appealing: The Latest Must-Know Appellate Action
If this month's circuit calendars were a March Madness bracket, we'd struggle to pick the top-seeded showdown. Big Pharma against the False Claims Act, or big business against President Donald Trump's visa fees? A big bank's view of "human life wagers," or en banc review in a State Farm class action?
-
March 04, 2026
CVS Beats Antitrust Suit Over 340B Drug Program, For Good
CVS Health Corp. permanently defeated a proposed antitrust class action alleging it forced hospitals in a discount drug program to use its third-party administrator for savings, when a Pennsylvania federal judge ruled Tuesday that hospitals aren't required to contract with CVS and can pick Walgreens or other participating pharmacies to contract with.
Expert Analysis
-
Opinion
A Uniform Federal Rule Would Curb Gen AI Missteps In Court
To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.
-
Riding The Changing Winds For AI Innovations At The USPTO
As recent U.S. Patent and Trademark Office moves reshape how artificial intelligence inventions will be examined and put them on firmer eligibility footing, practitioners need to consider how this shift is both an opportunity and a challenge, say Ryan Phelan at Marshall Gerstein and attorney Mark Campagna.
-
Series
The Law Firm Merger Diaries: Integrating Practice Groups
Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.
-
Nonprofits Face Uncertainty Over Political Activity Rules
Two federal court decisions suggesting that the Internal Revenue Service's rules for 501(c)(4) organizations' political activity may be too vague to survive constitutional scrutiny leave nonprofit organizations caught between constitutional limits on government regulation of speech and tax limits on their exempt status, say attorneys at BakerHostetler.
-
Opinion
Supreme Court Term Limits Would Carry Hidden Risk
While proposals for limiting the terms of U.S. Supreme Court justices are popular, a steady stream of relatively young, highly marketable ex-justices with unique knowledge and influence entering the marketplace of law and politics could create new problems, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.
-
Next Steps For Orgs. Amid Updated OpenAI Usage Policies
OpenAI's updates to its usage policies, clarifying that its tools are not substitutes for professional medical, legal or other regulated advice, sends a clear signal that organizations should mirror this clarity in their governance policies to mitigate compliance and liability exposure, say attorneys at Baker Donelson.
-
Series
Knitting Makes Me A Better Lawyer
Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.
-
How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation
On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, setting the stage for a decision that could drastically reduce enforcement under the False Claims Act, and presenting an opportunity to seek U.S. Supreme Court review of the act's whistleblower provisions, say attorneys at Epstein Becker.
-
Series
The Biz Court Digest: Welcome To Miami
After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.
-
How MAHA Is Taking Shape At The State Level
The national spotlight on the federal government's Make America Healthy Again movement is bolstering state-level actions regarding potential health impacts of certain food ingredients, increasing the difficulty and importance of maintaining effective compliance programs, say attorneys at Cooley.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.
-
Series
The Law Firm Merger Diaries: Getting The Message Across
Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.
-
Opinion
Horizontal Stare Decisis Should Not Be Casually Discarded
Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.
-
Key Takeaways From Armed Services Board's FY 2025 Report
The Armed Services Board of Contract Appeals’ annual report reveals an increase in new cases filed, but a decrease in cases resolved, and fewer parties choosing alternative dispute resolution, despite the likely reduction in time and expenses incurred during a prolonged appeal process, say attorneys at Miller & Chevalier.
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.